BATHINDA, June 4 -- The Central University of Punjab, Bathinda, has achieved a significant milestone in international biomedical research by participating in a global collaborative project to develop first-in-class therapeutics for acute myeloid leukaemia (AML), one of the most aggressive and difficult-to-treat blood cancers. The project has received funding under the Health-Holland International Kickstarter Call for Public-Private Partnerships 2025. CUP vice-chancellor Raghavendra P Tiwari said participation of institute in this international consortium reflects the growing global recognition of university's research ecosystem....